News Center

Company Announcement

Pause
1
2
3

Read More

Follow us on WeChat

Corporate News

2019/05/16

Johnson & Johnson Outlines Strategy to Deliver Above-Market Growth at 2019 Pharmaceutical Business Review

2018/03/27

Janssen joins partnership in China to provide access to SIRTURO? (bedaquiline) for the treatment of multidrug-resistant tuberculosis (MDR-TB)

2018/01/23

IMBRUVICA and REMICADE included on the Zhejiang Province Reimbursement List for Drugs Treating Major Illnesses

2017/11/13

XIAN JANSSEN LAUNCHES EARLY IMBRUVICA? (IBRUTINIB)

2017/09/25

【ChinaDaily】Serving in the name of progress

2017/09/21

Xian Janssen and Shaanxi Province Forestry Department Announce a New Phase of Collaboration to Protect Giant Pandas

2017/07/19

Xian Janssen: VELCADE? and ZYTIGA? Included on the NRDL 2017

2017/05/19

Johnson & Johnson Showcases Strong Pipeline of Transformational Medicines at its Pharmaceutical Business Review Meeting

Read More